Evidence map›Paper›PMID 41189772›Full record

ArticleRomanian journal of ophthalmology

Case report: Surgical and clinical results in bilateral lenticonus due to Alport syndrome.

Esen Çakmak-Cengiz, Fadime Karaman-Atasever, Ertuğrul Can

Abstract readCase Reports
In one paragraph

Article in Romanian journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Esen Çakmak-CengizÜnye State Hospital, Ordu, Turkey.
Fadime Karaman-AtaseverGaziosmanpaşa Education and Research Hospital, Istanbul, Turkey.
Ertuğrul CanDepartment of Ophthalmology, Ondokuz Mayis University Hospital, Samsun, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alport syndrome (AS) is a genetic disease characterized by hereditary nephritis, sensorineural hearing loss, and ocular anomalies. The most common ocular findings associated with AS include anterior lenticonus, retinal dot-fleck configuration, and corneal posterior polymorphism. Anterior lenticonus is 8 times more common in men with AS than in women. This case report evaluated the clinical and optical results obtained after phacoemulsification (PHACO) surgery and intraocular lens (IOL) implantation performed for bilateral anterior lenticonus due to AS. A 35-year-old male patient had complained of progressively decreasing vision for 10 years. The patient's ophthalmologic examination revealed bilateral anterior lenticonus and nuclear sclerosis. Continuous curvilinear capsulorhexis was applied in the anterior capsulorhexis method. Phacoemulsification surgery was performed using a high-viscoelastic material, starting the anterior capsulorhexis from the mid-periphery. The surgery was completed without anterior and posterior capsular rupture. Optimal postoperative refraction was achieved due to the IOL calculation performed using the traditional SRK-T formula. As a result, it has been shown that successful and uncomplicated results can be achieved with careful surgical technique and appropriate IOL selection in anterior lenticonus surgery due to AS.

Indexed as

Lens DiseasesLens Implantation, IntraocularNephritis, HereditaryPhacoemulsificationVisual AcuityAdultCapsulorhexisHumansMaleRefraction, OcularAlport syndromeanterior lenticonusAS = Alport syndromeBCVA = Best-corrected visual acuityCCC = Continuous curvilinear capsulorhexisD = DioptersIOL = Intraocular lensOCT = Optical coherence tomographyphacoemulsificationPHACO = PhacoemulsificationVEM = Viscoelastic material

Identifiers

PMID41189772
PMCPMC12580665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.